Cannabis Stocks Rally on Medical Research Findings
28
2
BTCCSquare news:
Tilray shares surged 5% Wednesday, outperforming the broader market's modest 0.4% gain. The rally followed a university study showing opioid prescription rates declined up to 22% in states with lenient cannabis laws.
Researchers from Georgia and Colorado analyzed millions of prescriptions between 2007-2020, revealing cannabis' potential as an alternative pain treatment. While opioids remain medically necessary, their addictive properties make safer alternatives increasingly valuable.
The findings strengthen the case for cannabis legalization, particularly as politicians seek data-driven policy solutions. Market reaction suggests investors anticipate growing acceptance of medical marijuana applications.
By:
